Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.

NCT06599424 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.

NCT NCT06599424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06599424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.
Lead sponsor
Heinrich-Heine University, Duesseldorf
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2023
Completion date
June 30, 2025
Enrollment
550 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, coronary artery disease, renal failure